Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Axogen (AXGN) over the last 15 years, with Q3 2025 value amounting to $1.6 million.

  • Axogen's Depreciation & Amortization (CF) fell 72.55% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 428.86%. This contributed to the annual value of $6.5 million for FY2024, which is 5331.91% up from last year.
  • Per Axogen's latest filing, its Depreciation & Amortization (CF) stood at $1.6 million for Q3 2025, which was down 72.55% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Axogen's Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q1 2025 and a low of $633000.0 during Q2 2021
  • Over the past 5 years, Axogen's median Depreciation & Amortization (CF) value was $797000.0 (recorded in 2023), while the average stood at $1.1 million.
  • In the last 5 years, Axogen's Depreciation & Amortization (CF) soared by 15146.58% in 2021 and then plummeted by 880.83% in 2022.
  • Axogen's Depreciation & Amortization (CF) (Quarter) stood at $685000.0 in 2021, then fell by 5.84% to $645000.0 in 2022, then surged by 141.55% to $1.6 million in 2023, then rose by 5.01% to $1.6 million in 2024, then grew by 0.37% to $1.6 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.6 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.